We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
-$25.3M
Cap. Flow
-$26.9M
Cap. Flow %
-15.18%
Top 10 Hldgs %
37.78%
Holding
91
New
22
Increased
14
Reduced
14
Closed
30

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.08M
2
SNY icon
Sanofi
SNY
+$3.58M
3
CI icon
Cigna
CI
+$2.81M
4
ABBV icon
AbbVie
ABBV
+$2.69M
5
AVXS
AveXis, Inc. Common Stock
AVXS
+$2.25M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$8.2M
2
MDCO
Medicines Co
MDCO
+$4.45M
3
SHPG
Shire pic
SHPG
+$3.71M
4
WBA
Walgreens Boots Alliance
WBA
+$2.91M
5
MRK icon
Merck
MRK
+$2.87M

Sector Composition

Rank Sector Weight
1 Healthcare 69.67%
2 Financials 2.79%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMU
26
DELISTED
Immunomedics Inc
IMMU
$2.87M 1.62%
325,000
-25,000
-7% -$176K
MRUS
27
DELISTED
Merus
MRUS
$2.77M 1.57%
175,000
– –
KPTI icon
28
Karyopharm Therapeutics
KPTI
$44.4M
$2.71M 1.53%
20,000
+1,667
+9% +$247K
NUVA
29
DELISTED
NuVasive, Inc.
NUVA
$2.69M 1.52%
35,000
-5,000
-13% -$374K
GKOS icon
30
Glaukos
GKOS
$10.7B
$2.49M 1.41%
60,000
-40,000
-40% -$1.72M
AVXS
31
DELISTED
AveXis, Inc. Common Stock
AVXS
$2.46M 1.39%
+30,000
New +$2.25M
CCXI
32
DELISTED
ChemoCentryx, Inc.
CCXI
$2.34M 1.32%
250,000
– –
BMRN icon
33
CALL
BioMarin Pharmaceuticals
BMRN
$12.6B
$2.27M 1.28%
+25,000
New +$2.27M
TSRO
34
DELISTED
TESARO, Inc.
TSRO
$2.1M 1.19%
+15,000
New +$2.17M
BIIB icon
35
Biogen
BIIB
$30.6B
$2.04M 1.15%
7,500
-2,500
-25% -$661K
XENT
36
DELISTED
Intersect ENT, Inc
XENT
$1.96M 1.11%
70,000
-30,000
-30% -$679K
ABT icon
37
Abbott
ABT
$188B
$1.94M 1.1%
40,000
-30,000
-43% -$1.36M
SGMO
38
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.89M 1.07%
215,000
+65,000
+43% +$417K
MDT icon
39
Medtronic
MDT
$113B
$1.77M 1%
+20,000
New +$1.69M
ANAB icon
40
AnaptysBio
ANAB
$1.67B
$1.68M 0.95%
70,000
+20,000
+40% +$503K
BSX icon
41
Boston Scientific
BSX
$73B
$1.52M 0.86%
+55,000
New +$1.46M
GWPH
42
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.5M 0.85%
+15,000
New +$1.61M
OMED
43
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.33M 0.75%
400,000
-90,000
-18% -$373K
IMMU
44
CALL
DELISTED
Immunomedics Inc
IMMU
$1.32M 0.75%
150,000
– –
AKAO
45
DELISTED
Achaogen Inc
AKAO
$1.3M 0.74%
60,000
– –
ZGNX
46
DELISTED
Zogenix, Inc.
ZGNX
$1.23M 0.7%
+85,000
New +$1.07M
EPZM
47
DELISTED
Epizyme, Inc
EPZM
$1.13M 0.64%
75,000
– –
DPLO
48
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.11M 0.63%
75,000
– –
WVE icon
49
Wave Life Sciences
WVE
$1.2B
$1.02M 0.58%
+55,000
New +$1.19M
CTMX icon
50
CytomX Therapeutics
CTMX
$741M
$930K 0.53%
60,000
-15,000
-20% -$226K
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2017 Portfolio in Review

As of Q2 2017, Iguana Healthcare Management held 91 positions worth $177M, down 13% from $202M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Iguana Healthcare Management withdrew a net $26.9M in Q2 2017, closing 30 positions and reducing 14 holdings. Its most notable exit was Amgen, an estimated $8.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 66% a quarter earlier, followed by Financials and Energy.

Against the trend, Iguana Healthcare Management opened a new position in Eli Lilly worth $4.12M.

  • Iguana Healthcare Management's largest Q2 2017 buy was Eli Lilly: 50,000 shares worth $4.12M.
  • Iguana Healthcare Management added most to Allergan plc in Q2 2017, an estimated $1.76M increase.
  • Iguana Healthcare Management's biggest Q2 2017 reduction was Medicines Co, cutting an estimated $4.45M.
  • Iguana Healthcare Management fully exited Amgen in Q2 2017, selling an estimated $8.2M.
  • Iguana Healthcare Management's ten largest holdings make up 38% of its $177M portfolio in Q2 2017.
  • Iguana Healthcare Management opened 22 new positions and closed 30 in Q2 2017.
  • Iguana Healthcare Management's portfolio value fell 13% quarter-over-quarter to $177M.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.